Quantcast
Environmental Health Perspectives Free Trail Issue
Author Keyword Title Full
About EHP Publications Past Issues News By Topic Authors Subscribe Press International Inside EHP Email Alerts spacer
Environmental Health Perspectives (EHP) is a monthly journal of peer-reviewed research and news on the impact of the environment on human health. EHP is published by the National Institute of Environmental Health Sciences and its content is free online. Print issues are available by paid subscription.DISCLAIMER
spacer
NIEHS
NIH
DHHS
spacer
Current Issue

EHP Science Education Website




Comparative Toxicogenomics Database (CTD)

spacer
Environmental Health Perspectives Volume 105, Number 1, January 1997 Open Access
spacer
Tracking Toxicants 
Tracking Toxicants

Carol Potera

Abstract


After years of discord, there may finally be a means of testing products that pleases both animal rights activists and scientists.

Xenometrix Incorporated has developed a line of stress gene assays that are based on the principle that cells respond in certain well-defined ways when exposed to toxic substances. Cells have "stress genes" that, when triggered by certain conditions, fight toxicants by either neutralizing them or repairing the cellular damage they have caused. There are basic stress genes that vary little from lower to higher species so, for example, scientists can use stress genes from bacteria to extrapolate data for humans. The assays are targeted at a variety of specific users' needs, such as the CAT-Tox(Skin) assay that is currently being evaluated by Mary Kay Cosmetics for testing their skin-care products.

Other companies, who have already found ways to replace animal experimentation, can still benefit from the stress gene assays because they provide information that has never before been available. The stress gene assays are far more sensitive than other assays and are better predictors of future biological changes. For some applications, they also provide a quicker response than standard assays. The stress gene assays do not provide information on the intact whole animal and, though they return less ambiguous results than most assays, they can still be difficult to interpret. The hefty price tag is also a deterrent to some users. However, to proponents of the assays, the benefits far outweigh the limitations.

The assays are only two years old and, to date, no company has actually abandoned animal experimentation in favor of the new assays. Nevertheless, industry insiders predict that the stress gene assays will eventually replace animal experimentation altogether and become "the toxicity characterization method of the future."


The full version of this article is available for free in HTML format.
spacer
 
Open Access Resources | Call for Papers | Career Opportunities | Buy EHP Publications | Advertising Information | Subscribe to the EHP News Feeds News Feeds | Inspector General USA.gov